William Blair & Company’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-12,800
| Closed | -$186K | – | 1906 |
|
|
2021
Q4 | $186K | Buy |
12,800
+2,750
| +27% | +$40K | ﹤0.01% | 1598 |
|
|
2021
Q3 | $181K | Buy |
+10,050
| New | +$181K | ﹤0.01% | 1519 |
|
|
2020
Q2 | – | Sell |
-10,600
| Closed | -$11K | – | 1675 |
|
|
2020
Q1 | $11K | Sell |
10,600
-8,072
| -43% | -$8.38K | ﹤0.01% | 1550 |
|
|
2019
Q4 | $35K | Sell |
18,672
-2,530
| -12% | -$4.74K | ﹤0.01% | 1523 |
|
|
2019
Q3 | $23K | Sell |
21,202
-39,180
| -65% | -$42.5K | ﹤0.01% | 1527 |
|
|
2019
Q2 | $132K | Buy |
60,382
+9,726
| +19% | +$21.3K | ﹤0.01% | 1387 |
|
|
2019
Q1 | $303K | Sell |
50,656
-6,072
| -11% | -$36.3K | ﹤0.01% | 1146 |
|
|
2018
Q4 | $419K | Buy |
56,728
+11,570
| +26% | +$85.5K | ﹤0.01% | 970 |
|
|
2018
Q3 | $656K | Sell |
45,158
-44,397
| -50% | -$645K | ﹤0.01% | 871 |
|
|
2018
Q2 | $1.79M | Buy |
89,555
+49,429
| +123% | +$987K | 0.01% | 581 |
|
|
2018
Q1 | $703K | Sell |
40,126
-5,321
| -12% | -$93.2K | 0.01% | 808 |
|
|
2017
Q4 | $1.12M | Buy |
45,447
+30,975
| +214% | +$764K | 0.01% | 715 |
|
|
2017
Q3 | $374K | Buy |
14,472
+797
| +6% | +$20.6K | ﹤0.01% | 1032 |
|
|
2017
Q2 | $371K | Buy |
+13,675
| New | +$371K | ﹤0.01% | 1075 |
|